Are You Covered for the Future of Aesthetics?
One of the big topics of conversation at the British College of Aesthetic Medicine’s (BCAM) conference this year was regenerative aesthetics. This approach to treatment has taken the UK by storm in recent years and is only set to get bigger.
A growing market
The overall regenerative medicine market is predicted to be worth approximately USD 194.9 billion by 2032, up from USD 34.6 billion in 2022. Much of this comes from demand to be able to treat diseases such as cancer, heart disease and diabetes in our ageing population, while the significant growth in stem cell research is providing new and innovative treatment options.
Future predictions suggest that we can expect to see increased focus on gene therapy for skin rejuvenation, nano fat grafting, 3D printed skin grafts and AI-powered diagnostic tools.
Aesthetic adaptation
As we know in the aesthetics world, stem cell-based skincare is increasingly popular, while biological treatment options that can stimulate aged and damaged fibroblasts to improve skin quality are in huge demand.
It was great to see BCAM’s focus on regenerative options, with sessions dedicated to leading biostimulators; Sculptra, Polynucleotide HPT and HarmonyCA. Dr Beatriz Molina also shared an excellent presentation on the future of aesthetics through regeneration, providing a fascinating insight into how regenerative treatments can be integrated into your treatment portfolio and complement existing procedures.
Regenerative aesthetics in your clinic
After hearing the talks, how many of you are now considering adding a regenerative treatment to your clinic offering?
From what products to choose to how to advertise your new treatments to patients, there’s a lot to consider! One thing we can help with is ensuring you have the right insurance in place.
Like any aesthetic treatment, having Medical Malpractice Insurance coverage in place is essential. For BCAM members, we created a package that can support members with best practices and arrange coverage for medical malpractice.
